Retrospective Study Demonstrating High Rates of Sustained Virologic Response After Treatment With Direct-Acting Antivirals Among American Indian/Alaskan Natives
Authors: Jorge Mera, Kartik Joshi, Karla Thornton, Terry Box, John Scott, Miranda Sedillo, Paulina Deming, Crystal David, Whitney Essex, Richard Manch, Anita Kohli, Anita Kohli
Publication Year: 2019
Last Updated: 2021-04-28
Journal: Infectious Diseases Society of America
Keywords: Health Disparities
Short Abstract:
The article explores the treatment for chronic hepatitis C. The virus (HCV) has rapidly evolved to simple, well-tolerated, all-oral regimens of direct-acting antivirals (DAAs). There is few data on the epidemiology of HCV in American Indians/Alaska Natives (AI/ANs), a population disproportionately affected by HCV. The article concluded that there are more steps must be taken to increase access to treatment for this underserved, vulnerable population.
Abstract:
The article explores the treatment for chronic hepatitis C. The virus (HCV) has rapidly evolved to simple, well-tolerated, all-oral regimens of direct-acting antivirals (DAAs). There is few data on the epidemiology of HCV in American Indians/Alaska Natives (AI/ANs), a population disproportionately affected by HCV. The article concluded that there are more steps must be taken to increase access to treatment for this underserved, vulnerable population.
File Download:
Source: Link to Original Article.
Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610205/
